EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,321,925 | +14.3% | 60,500 | 0.0% | 0.41% | +27.0% |
| Q2 2023 | $1,156,155 | -1.5% | 60,500 | 0.0% | 0.32% | +3.2% |
| Q1 2023 | $1,174,305 | +21.0% | 60,500 | 0.0% | 0.31% | +25.3% |
| Q4 2022 | $970,420 | +1.5% | 60,500 | -0.8% | 0.25% | +7.3% |
| Q3 2022 | $956,000 | -25.9% | 61,000 | -1.6% | 0.23% | -15.0% |
| Q2 2022 | $1,291,000 | -8.2% | 62,000 | 0.0% | 0.27% | +12.3% |
| Q1 2022 | $1,406,000 | +24.1% | 62,000 | 0.0% | 0.24% | +50.0% |
| Q4 2021 | $1,133,000 | -13.6% | 62,000 | 0.0% | 0.16% | -14.7% |
| Q3 2021 | $1,311,000 | +16.0% | 62,000 | 0.0% | 0.19% | +25.8% |
| Q2 2021 | $1,130,000 | -20.6% | 62,000 | -1.6% | 0.15% | -25.2% |
| Q1 2021 | $1,423,000 | +10.8% | 63,000 | -1.6% | 0.20% | +12.2% |
| Q4 2020 | $1,284,000 | -18.0% | 64,000 | 0.0% | 0.18% | -33.1% |
| Q3 2020 | $1,565,000 | -26.8% | 64,000 | -28.9% | 0.27% | -21.3% |
| Q2 2020 | $2,137,000 | -4.6% | 90,000 | -30.8% | 0.34% | -6.0% |
| Q1 2020 | $2,239,000 | -20.6% | 130,000 | -18.8% | 0.36% | +27.3% |
| Q4 2019 | $2,819,000 | -8.9% | 160,000 | -8.6% | 0.29% | -9.2% |
| Q3 2019 | $3,095,000 | -17.2% | 175,000 | 0.0% | 0.32% | -13.2% |
| Q2 2019 | $3,740,000 | -10.2% | 175,000 | 0.0% | 0.36% | -11.9% |
| Q1 2019 | $4,165,000 | +21.0% | 175,000 | 0.0% | 0.41% | +9.6% |
| Q4 2018 | $3,442,000 | +11.0% | 175,000 | 0.0% | 0.38% | +38.2% |
| Q3 2018 | $3,101,000 | -20.0% | 175,000 | -2.8% | 0.27% | -21.2% |
| Q2 2018 | $3,874,000 | -8.0% | 180,000 | -5.3% | 0.34% | -13.3% |
| Q1 2018 | $4,209,000 | -27.1% | 190,000 | 0.0% | 0.40% | -25.0% |
| Q4 2017 | $5,776,000 | +25.5% | 190,000 | 0.0% | 0.53% | +24.4% |
| Q3 2017 | $4,604,000 | -1.6% | 190,000 | 0.0% | 0.43% | -7.2% |
| Q2 2017 | $4,680,000 | +13.7% | 190,000 | 0.0% | 0.46% | +13.0% |
| Q1 2017 | $4,117,000 | +45.3% | 190,000 | 0.0% | 0.41% | +43.3% |
| Q4 2016 | $2,833,000 | +10.8% | 190,000 | -5.0% | 0.28% | +26.8% |
| Q3 2016 | $2,558,000 | +63.8% | 200,000 | 0.0% | 0.22% | +58.9% |
| Q2 2016 | $1,562,000 | +95.2% | 200,000 | 0.0% | 0.14% | +90.5% |
| Q1 2016 | $800,000 | -29.1% | 200,000 | 0.0% | 0.07% | -26.7% |
| Q4 2015 | $1,128,000 | +0.5% | 200,000 | 0.0% | 0.10% | +18.8% |
| Q3 2015 | $1,122,000 | +49.2% | 200,000 | 0.0% | 0.08% | +63.5% |
| Q2 2015 | $752,000 | +46.3% | 200,000 | 0.0% | 0.05% | +48.6% |
| Q1 2015 | $514,000 | +78.5% | 200,000 | 0.0% | 0.04% | +84.2% |
| Q4 2014 | $288,000 | -5.9% | 200,000 | 0.0% | 0.02% | -13.6% |
| Q3 2014 | $306,000 | – | 200,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |